Northwest Biotherapeutics, Inc.
NWBO
$0.1901
-$0.0039-2.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -26.00% | 2.01% | 16.26% | 16.56% | -65.13% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -16.25% | 7.54% | -15.18% | 23.56% | 14.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.76% | 4.34% | 0.57% | 19.95% | -51.19% |
|
|
|||||
| Total Current Assets | -21.76% | 4.34% | 0.57% | 19.95% | -51.19% |
| Net Property, Plant & Equipment | -6.66% | 4.19% | -1.78% | -0.57% | 3.35% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.41% | 0.54% | 2.48% | 0.55% | 1.12% |
| Total Assets | -8.84% | 3.88% | -1.20% | 2.52% | -11.52% |
|
|
|||||
| Total Accounts Payable | -5.27% | 18.29% | 0.36% | 47.30% | -16.92% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 87.22% | -14.68% | -26.75% | 207.43% | -51.89% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.38% | -2.00% | -2.04% | 32.66% | 19.76% |
| Total Finance Division Other Current Liabilities | 31.60% | 23.03% | -20.36% | -9.13% | -3.13% |
| Total Other Current Liabilities | 31.60% | 23.03% | -20.36% | -9.13% | -3.13% |
| Total Current Liabilities | 14.62% | 6.03% | -10.04% | 38.13% | -8.16% |
|
|
|||||
| Total Current Liabilities | 14.62% | 6.03% | -10.04% | 38.13% | -8.16% |
| Long-Term Debt | 15.64% | 19.75% | 100.04% | -49.71% | 84.02% |
| Short-term Debt | 87.22% | -14.68% | -26.75% | 207.43% | -51.89% |
| Capital Leases | -8.08% | 10.71% | -0.52% | -1.57% | 7.74% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -6.00% | 0.00% | 1.01% | 8.79% |
| Total Liabilities | 12.98% | 8.83% | 4.79% | 9.50% | 8.67% |
|
|
|||||
| Common Stock & APIC | 0.81% | 1.37% | 1.12% | 0.79% | 1.57% |
| Retained Earnings | -1.99% | -1.39% | -1.30% | -1.35% | -1.41% |
| Treasury Stock & Other | 2,844.44% | -105.03% | 3.57% | 42.14% | -54.62% |
| Total Common Equity | -17.94% | -4.73% | -4.39% | -11.42% | -1.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -2.33% | -15.34% | -5.34% | 5.83% | -32.34% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -2.33% | -15.34% | -5.34% | 5.83% | -32.34% |
|
|
|||||
| Total Common Equity | -17.94% | -4.73% | -4.39% | -11.42% | -1.00% |
| Total Preferred Equity | -2.33% | -15.34% | -5.34% | 5.83% | -32.34% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.95% | -11.25% | -7.99% | -13.64% | -25.64% |
|
|
|||||
